Form 8-K - Current report:
SEC Accession No. 0001628280-18-003148
Filing Date
2018-03-13
Accepted
2018-03-13 17:05:09
Documents
1
Period of Report
2018-03-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kitem801anda31318.htm 8-K 25688
  Complete submission text file 0001628280-18-003148.txt   26822
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 18687249
SIC: 2834 Pharmaceutical Preparations